Novel Drug Therapies for Cardiac Amyloidosis

Authors

Prakash Harikrishnan, New York Medical CollegeFollow
Srikanth Yandrapalli, New York Medical College
Wilbert S. Aronow, New York Medical CollegeFollow
Gregg M. Lanier, New York Medical CollegeFollow
Diwakar Jain, New York Medical CollegeFollow

DOI

10.1080/13543784.2019.1619695

Journal Title

Expert Opinion on Investigational Drugs

First Page

497

Last Page

499

Document Type

Article

Publication Date

June 2019

Department

Medicine

Keywords

Cardiac amyloidosis, cardiomyopathy, drugs, light chain, transthyretin

Disciplines

Medicine and Health Sciences

Recommended Citation

Harikrishnan, P., Yandrapalli, S., Aronow, W., Lanier, G., & Jain, D. (2019). Novel Drug Therapies for Cardiac Amyloidosis. Expert Opinion on Investigational Drugs, 28 (6), 497-499. https://doi.org/10.1080/13543784.2019.1619695